Depression Clinical Trial
Official title:
Interpersonally Focused Psychodynamic Group Psychotherapy as Adjunct Treatment for Residual Symptoms of Major Depressive Disorder
Depression and anxiety disorders, even when treated according to standard of care consisting of individual treatment with medication and/or therapy, can be associated with significant residual impact on quality of life. The purpose of this research is carry out an observational study of an existing clinical treatment, adjunctive interpersonally focused psychodynamic group therapy, to determine if this can improve quality of life for patients who have residual symptoms of chronic depression and anxiety.
Patients will be referred from primary individual therapist at the Stanford psychiatry
outpatient clinics or community. Patients meeting inclusion criteria will be contacted for
consent to participate in intake process consisting of objective evaluation with Patient
Health Questionnaire (PHQ9; assessment of mood), Generalized Anxiety Disorder Scale (GAD7;
assessment of anxiety), Psychological General Well-Being Index (PGWBI), adult attachment
style questionnaire (ASQ), and the interpersonal communication inventory (ICI), followed by
standardized interpersonally oriented intake interview. Test and interview administration
will be done by resident psychiatrists with training by supervising psychiatry faculty. A
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) diagnosis will be obtained
using the Mini-International Neuropsychiatric Interview (MINI). Patients entered on
antidepressants will be held at a stable dosage. Patients will be required to continue to
see their individual therapist throughout the duration of their participation in the study,
and will be asked for consent for group leaders to speak with individual therapist as
clinically indicated.
A total of 25 patients are projected to be entered into the group. Rolling enrollment will
proceed to maintain a minimum of 5 and maximum of 10 people in the group, as expected group
therapy drop-out rates are on the order of 30%. This number of people is expected to provide
sufficient group membership for effective interpersonal psychodynamic group therapy. The
group will use psychodynamic principles tailored to the group setting, which focus on
interpersonal dynamics happening within the group in real-time, as described in Dr. Irvin
Yalom's Group Psychotherapy text. Sessions will be 75 minutes in length on a weekly basis.
Sessions will be led by two senior (4th year) psychiatry residents and videotaped for
supervision by two faculty psychiatrists. During the study, all group members will complete
PHQ9, GAD7, and Sheehan disability scale prior to each group therapy session. The full
battery of objective assessments delivered at the start of the study will be repeated every
6 months. Study will involve group participation for six months, with the option to continue
in the group afterwards. Subjects who withdraw prior to 6 months will be asked to complete
the full battery of objective assessments otherwise administered every 6 months and their
data will be used as pilot data examining outcomes at intermediary time points.
Additionally, age and gender matched patients who meet inclusion criteria but are unable to
attend group sessions due to scheduling conflict will be given objective scales described
above at screening and at 6 months (or earlier if clinical or treatment status changes).
This group will act as control. They will continue to engage in their typical individual
psychiatric care, as the goal of this study is to examine additional benefit of adjunct
group therapy above individual therapy alone.
;
Observational Model: Case Control, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05777044 -
The Effect of Hatha Yoga on Mental Health
|
N/A | |
Recruiting |
NCT04680611 -
Severe Asthma, MepolizumaB and Affect: SAMBA Study
|
||
Recruiting |
NCT04977232 -
Adjunctive Game Intervention for Anhedonia in MDD Patients
|
N/A | |
Recruiting |
NCT04043052 -
Mobile Technologies and Post-stroke Depression
|
N/A | |
Completed |
NCT04512768 -
Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy
|
N/A | |
Recruiting |
NCT03207828 -
Testing Interventions for Patients With Fibromyalgia and Depression
|
N/A | |
Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
Completed |
NCT04476446 -
An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives
|
Phase 3 | |
Recruiting |
NCT02783430 -
Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease
|
Phase 2/Phase 3 | |
Recruiting |
NCT05563805 -
Exploring Virtual Reality Adventure Training Exergaming
|
N/A | |
Completed |
NCT04598165 -
Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support
|
N/A | |
Completed |
NCT03457714 -
Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
|
||
Recruiting |
NCT05956912 -
Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
|
||
Completed |
NCT05588622 -
Meru Health Program for Cancer Patients With Depression and Anxiety
|
N/A | |
Recruiting |
NCT05234476 -
Behavioral Activation Plus Savoring for University Students
|
N/A | |
Active, not recruiting |
NCT05006976 -
A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study
|
N/A | |
Enrolling by invitation |
NCT03276585 -
Night in Japan Home Sleep Monitoring Study
|
||
Terminated |
NCT03275571 -
HIV, Computerized Depression Therapy & Cognition
|
N/A | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A |